Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency
Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Prion diseases, such as the sporadic Creutzfeldt–Jakob disease (sCJD), are a class of fatal neurodegenerative disorders. Currently, there is no efficient treatment or therapy available. Hence, the search for molecules that may inhibit the conversion of the cellular prion protein (PrP
C
) into its pathological counterpart PrPScrapie (PrP
Sc...
Alternative Titles
Full title
Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2385585334
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2385585334
Other Identifiers
ISSN
0893-7648
E-ISSN
1559-1182
DOI
10.1007/s12035-019-01837-w
